1 completed, 1 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Osteogenesis Imperfecta, Type I: new trials by email Literature Review of Osteogenesis Imperfecta, Type I trials Research Report on Osteogenesis Imperfecta, Type I
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Interventional Study to Evaluate the Impact of Blood Flow Restriction Training on Muscle, Bone, and Quality of Life in Adults With Osteogenesis Imperfecta Type I Blood flow restriction training - Osteogenesis Imperfecta, Type I | Not applicable | Recruiting | University Hospital, Ghent | 40 | 2025-08-19 | 2026-03-17 |
| A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804 setrusumab, Calcium, Vitamin D - Osteogenesis Imperfecta, Type I, Osteogenesis Imperfecta Type III | Phase 2 | Completed | Ultragenyx Pharmaceutical Inc | 112 | 2017-09-11 | 2023-07-05 |
Osteogenesis Imperfecta (2) · Motor Activity (1) · Osteogenesis imperfecta, type 3 (1)
Bone Diseases (2) · Bone Diseases, Developmental (2) · Collagen Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Connective Tissue Diseases (2) · Genetic Diseases, Inborn (2) · Musculoskeletal Diseases (2) · Osteochondrodysplasias (2) · Skin and Connective Tissue Diseases (2) · Behavior (1)
Blood Flow Restriction Therapy (1) · Calcium (1) · Vitamin D (1) · Zoledronic Acid (1) · setrusumab (1)
Ultragenyx Pharmaceutical Inc (1) · University Hospital, Ghent (1)
Belgium (1) · Canada (1) · Denmark (1) · France (1) · United Kingdom (1) · United States (1)
Charlotte Verroken, PhD, MD (1)
2016 (1)